ArticleMolecular cancer therapeutics2025

Targeting CDK7 Enhances the Antitumor Efficacy of Enzalutamide in Androgen Receptor-Positive Triple-Negative Breast Cancer by Inhibiting c-MYC-mediated Tumorigenesis.

Xuemei Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.